BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21906804)

  • 41. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins.
    Slowing II; Trewyn BG; Lin VS
    J Am Chem Soc; 2007 Jul; 129(28):8845-9. PubMed ID: 17589996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parameters affecting the efficient delivery of mesoporous silica nanoparticle materials and gold nanorods into plant tissues by the biolistic method.
    Martin-Ortigosa S; Valenstein JS; Sun W; Moeller L; Fang N; Trewyn BG; Lin VS; Wang K
    Small; 2012 Feb; 8(3):413-22. PubMed ID: 22174078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
    Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
    Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
    Slowing I; Trewyn BG; Lin VS
    J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT.
    Gary-Bobo M; Hocine O; Brevet D; Maynadier M; Raehm L; Richeter S; Charasson V; Loock B; Morère A; Maillard P; Garcia M; Durand JO
    Int J Pharm; 2012 Feb; 423(2):509-15. PubMed ID: 22178618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.
    Sun TM; Du JZ; Yan LF; Mao HQ; Wang J
    Biomaterials; 2008 Nov; 29(32):4348-55. PubMed ID: 18715636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface engineering of gold nanoparticles for in vitro siRNA delivery.
    Zhao E; Zhao Z; Wang J; Yang C; Chen C; Gao L; Feng Q; Hou W; Gao M; Zhang Q
    Nanoscale; 2012 Aug; 4(16):5102-9. PubMed ID: 22782309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
    Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting of porous hybrid silica nanoparticles to cancer cells.
    Rosenholm JM; Meinander A; Peuhu E; Niemi R; Eriksson JE; Sahlgren C; Lindén M
    ACS Nano; 2009 Jan; 3(1):197-206. PubMed ID: 19206267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
    Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
    Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on the adsorption mechanism of DNA with mesoporous silica nanoparticles in aqueous solution.
    Li X; Zhang J; Gu H
    Langmuir; 2012 Feb; 28(5):2827-34. PubMed ID: 22182067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of mesoporous silica nanoparticles.
    Wu SH; Mou CY; Lin HP
    Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.
    Xie M; Shi H; Ma K; Shen H; Li B; Shen S; Wang X; Jin Y
    J Colloid Interface Sci; 2013 Apr; 395():306-14. PubMed ID: 23394807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Core-shell designs of photoluminescent nanodiamonds with porous silica coatings for bioimaging and drug delivery II: application.
    Prabhakar N; Näreoja T; von Haartman E; Karaman DŞ; Jiang H; Koho S; Dolenko TA; Hänninen PE; Vlasov DI; Ralchenko VG; Hosomi S; Vlasov II; Sahlgren C; Rosenholm JM
    Nanoscale; 2013 May; 5(9):3713-22. PubMed ID: 23493921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
    Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
    J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
    Jin H; Lovell JF; Chen J; Lin Q; Ding L; Ng KK; Pandey RK; Manoharan M; Zhang Z; Zheng G
    Bioconjug Chem; 2012 Jan; 23(1):33-41. PubMed ID: 22142191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.